期刊文献+

1例隐源性机化性肺炎患者的药学监护 被引量:1

Pharmaceutical Care for One Case of Cryptogenic Organizing Pneumonia
下载PDF
导出
摘要 目的:临床药师通过参与1例隐源性机化性肺炎患者的治疗实践,为临床药师参与临床实践提供思路。方法:以具体病例为例,介绍临床药师协助医师制订治疗方案、对治疗进行全程药学监护。结果:临床药师参与治疗实践,在与临床医师共同制定治疗方案的同时对患者进行药学监护,提高了临床治疗效果。结论:临床药师参与药物治疗,为患者提供个体化药学服务,可使用药更安全、有效和经济。 OBJECTIVE: To provide insights for clinical pharmacists to take part in clinical practice through involvement in treatment practice for one patient with cryptogenic organizing pneumonia. METHODS: With specific case as the example, this paper introduces clinical pharmacists' assisting clinicians in making therapeutic regimen and providing pharmaceutical care for patient throughout treatment course. RESULTS : Clinical pharmacist' s involvement in treatment practice to cooperate with clinician in making therapeutic regimen and providing pharmaceutical care for patients resulted in improvement of clinical curative efficacy. CONCLUSION: Clinical pharmacist' s involvement in treatment practice to provide individualized pharmaceutical care contributed to safe, effective and economic medication.
作者 汪峰 凌艺兰
出处 《中国医院用药评价与分析》 2013年第7期669-671,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 临床药师 隐源性机化性肺炎 药学监护 Clinical pharmacist Cryptogenic organizing pneumonia Pharmaceutical care
  • 相关文献

参考文献10

  • 1American Thoracic Society, European RespiratorySociety. American Thoracic Society/European RespiratorySociety International Multidisciplinary Consensus Classifi-cation of the Idiopathic Interstitial Pneumonias. This jointstatement of the American Thoracic Society ( ATS),andthe European Respiratory Society ( ERS) was adopted bythe ATS board of directors, June 2001 and by the ERSExecutive Committee, June 2001 [ J]. Am J Respir CritCare Med ,2002,165 (2) : 277-304.
  • 2Davison AG, Heard BE, McAllister WA, et al.Cryptogenic organizing pneumonitis [ J]. Q J Med,1983,52(207) ;382-394.
  • 3陈海红,李华茵,卢韶华,何礼贤.隐源性机化性肺炎的临床分析[J].中国临床医学,2010,17(2):175-178. 被引量:8
  • 4蔡后荣,侯杰.隐原性机化性肺炎的临床、病理和影像学诊断[J].中国医学影像技术,2005,21(7):1133-1136. 被引量:16
  • 5社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3065
  • 6陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 7周艳,赵弘卿.隐源性机化性肺炎的诊治进展[J].中国呼吸与危重监护杂志,2011,10(1):96-98. 被引量:10
  • 8Cordier JF. Update on eryptogenic organizing pneumonia(idiopathic bromchiolitis obliterans organizing pneu-monia) [J]. Swiss Med Wkfy, 2002,132 (4142) : 588-591.
  • 9Drakopanagiotakis F, Polychmnopoulos V,Judson MA.Organizing pneumonia[ J]. Am J Med Sci,2008 ,335 ( 1):34-39.
  • 10吴永佩,颜青.医院药学与药学人才定位的探讨[J].中国药房,2008,19(22):1687-1689. 被引量:35

二级参考文献74

共引文献4811

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部